Karen R. Rabin, MD, PhD
- Cancer and Blood Disorders
Director, Leukemia Program
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Office location:
1102 Bates Avenue
Houston, TX 77030
Get to know Karen R. Rabin, MD, PhD
Dr. Karen Rabin is Director of the Leukemia Program. Her clinical interests include acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Her research interests focus on prognosis, management, and genomics of ALL, with special interests in ALL in children with Down syndrome; and disparities in ALL outcomes in Hispanics.
Education
School | Education | Degree | Year |
---|---|---|---|
Baylor College of Medicine | PhD | Doctor of Philosophy, Clinical Investigation | 2010 |
Stanford University School of Medicine | Fellowship | Pediatric Hematology-Oncology | 2004 |
University of California San Francisco | Residency | Pediatrics | 2001 |
University of California San Francisco | Medical School | Doctor of Medicine | 1998 |
Harvard University | Bachelors | Bachelor of Arts, Psychology | 1991 |
Organizations
Organization Name | Role |
---|---|
American Association of Pediatrics (AAP) | Member |
American Society of Hematology (ASH) | Member |
American Society of Pediatric Hematology and Oncology (ASPHO) | Member |
Children's Oncology Group (COG) | Member |
Board Certifications
American Board of Pediatrics - Pediatric Hematology/Oncology
American Board of Pediatrics - Pediatrics
Honors and awards
- 2021
-
Children’s Oncology Group Young Investigators Committee Award for Excellence in Mentoring
- 2021
-
Power of Professionalism Award, Baylor College of Medicine
- 2012
-
Fulbright & Jaworski Faculty Education Award for Excellence in Teaching and Evaluation
- 2010-2015
-
St. Baldrick’s Foundation Research Scholar
- 2009-2010
-
Hyundai Pediatric Cancer Research Scholar
- 2005-2009
-
K12 Faculty Fellowship in Pediatric Oncology Clinical Research
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Research Area:
Cancer Survivorship
Leukemia
Dr. Karen Rabin has research interests in genomics and management of childhood acute lymphoblastic leukemia (ALL), with particular areas of interest in ALL in children with Down syndrome, and disparities in childhood leukemia outcomes in Latinos. Dr. Rabin is a member of the Children’s Oncology Group (COG) ALL Executive Committee, Vice Chair of ALL Biology for COG, and Vice Chair of the current COG trial AALL1731 for children with Standard Risk and Down Syndrome ALL.